Modalità suggerimenti è attiva Disattiva

NewAmsterdam Pharma, ordinary share
NL00150012L7, NAMS

Aggiungi un'azione al WL
Seleziona tutto Ripristina i parametri
NewAmsterdam Pharma, paese — Paesi Bassi
Dati sugli scambi assenti
È possibile modificare la visualizzazione dei dati sul grafico | tabella
Fonte di informazioni - S.p.A. "Borsa di Mosca" È vietata ogni distribuzione di tali informazioni senza l'esplicito permesso e consenso di S.p.A. "Borsa di Mosca".
Fonte di informazioni - S.p.A. "Borsa di Mosca" È vietata ogni distribuzione di tali informazioni senza l'esplicito permesso e consenso di S.p.A. "Borsa di Mosca".
da
a
AGGIUNGERE
Cbonds add-in API
bond data api
Occorre effettuare il login
i dati è necessario l'accesso
Più di 2500 risultati sono stati trovati, per favore specificare la vostra richiesta
Nessun dato per il periodo selezionato

Ultime quote

Utilizza il più completo database finanziario

800 000

obbligazioni

Oltre 400

fonti di prezzo

80 000

azioni

9 000

ETF

Monitora il tuo portafoglio nel modo più efficiente
bond screener
Watchlist
Excel ADD-IN
Ottieni l'accesso

Emittente

Profilo
NewAmsterdam Pharma operates as a pharmaceutical company. The Company focuses on the research and development of transformative therapies for cardio-metabolic diseases. NewAmsterdam Pharma serves customers in the Netherlands.
  • Emittente
  • Nome completo del mutuatario/emittente
    NewAmsterdam Pharma Co NV
  • Settore industriale
    Preparazione farmaceutica e biotecnologia

Rendicontazione IFRS/US GAAP

2024
I trim. ingl.
2023
IV trim. ingl.
2022
IV trim. ingl.
Mostra tutto Nascondi
Occorre effettuare il login
i dati è necessario l'accesso

Azione inclusa nell'indice

Indicatori

Notizie

09/05/2024 NewAmsterdam Pharma: Results Of Operations And Financial Condition, Financial Statements And Exhibits
28/03/2024 NewAmsterdam Pharma: , Including Exhibit 99.1, Is Being Furnished And Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liability Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended (the Securities Act ). The Information Contained In This Item 7.01, Including Exhibit 99.1, Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Pursuant To The Securities Act Or Into Any Filing Or Other Document Pursuant To The Exchange Act, Except As Otherwise Expressly Stated In Any Such Filing, Financial Statements And Exhibits
04/03/2024 NewAmsterdam Pharma: , Including Exhibit 99.1, Is Being Furnished And Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liability Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended (the Securities Act ). The Information Contained In This Item 7.01, Including Exhibit 99.1, Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Pursuant To The Securities Act Or Into Any Filing Or Other Document Pursuant To The Exchange Act, Except As Otherwise Expressly Stated In Any Such Filing, Financial Statements And Exhibits
28/02/2024 NewAmsterdam Pharma: Of This Current Report On Form, Financial Statements And Exhibits
13/02/2024 NewAmsterdam Pharma: The Information Contained In This Item 7.01, Including Exhibits 99.1 And 99.2, Is Being Furnished And Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liability Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act. The Information Contained In This Item 7.01, Including Exhibits 99.1 And 99.2, Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Pursuant To The Securities Act Or Into Any Filing Or Other Document Pursuant To The Exchange Act, Except As Otherwise Expressly Stated In Any Such Filing, Financial Statements And Exhibits
Notizie societari

Altre azioni e certificati di deposito

Detentori di titolo

Industry Leaders

La registrazione è richiesta per ottenere l'accesso.